additional week of expectant management and delivery at 39 weeks. Maternal outcomes of interest were cesarean delivery, operative vaginal delivery, perineal tear, chorioamnionitis, and endomyometritis. Neonatal outcomes of interest were intrauterine fetal death, 5 minute Apgar less than 7, NICU admission, respiratory distress syndrome (RDS), hypoglycemia, hypoxic ischemic encephalopathy (HIE) and jaundice. Results were compared using chi square analysis and examined using multivariate logistic regression. A p-value of less than 0.05 was used to indicate statistical significance. RESULTS: In our cohort of 231,567 deliveries, there were significant differences in the incidence of cesarean delivery, perineal tears, chorioamnionitis, and endomyometritis in women who were electively induced at 38 weeks compared to those who received expectant management and delivered at 39 weeks. However, the rate of operative vaginal delivery was not significantly different between the two groups. The rate of intrauterine fetal death was also significantly decreased when women were electively induced at 38 weeks. Logistic regression analysis indicated expectant management for one additional week, with delivery at 39 weeks, significantly increased cesarean deliveries (OR 1.45, 95% CI 1.37-1.54) but decreased RDS in neonates (OR 0.83, 95% CI 0.71-0.98). There were no differences between the two groups for neonatal outcomes of hypoglycemia, HIE and jaundice. CONCLUSION: The maternal and neonatal outcomes following birth are associated with the timing and management prior to delivery. These findings can be used to counsel women regarding the risks of maternal and neonatal complications from elective induction of labor and expectant management for one additional week.
692 Obstructive sleep apnea is an unrecognized contributor to fatigue in pregnancy D'Angela S. Pitts, Patricia Greco, Louise M. O'Brien University of Michigan, Ann Arbor, MI OBJECTIVE: Pregnant women often complain of fatigue but this is generally thought to be part of pregnancy due to hormonal changes. In the non-pregnant population obstructive sleep apnea (OSA) is a known contributor to fatigue but this has not been investigated in pregnant women. We therefore examined whether underlying OSA plays a role in fatigue during pregnancy. STUDY DESIGN: A secondary analysis of home sleep tests conducted among pregnant women for research purposes. All women were queried about symptoms of fatigue and daytime sleepiness using a fatigue scale and the Epworth Sleepiness Scale respectively. Women who reported that they experienced fatigue "often" were classified as cases. Excessive daytime sleepiness was considered present with a sleepiness score of !10. The presence of OSA was determined by an overnight home sleep test with an apnea-hypopnea index of !5 events/hour. Demographics and medical information was obtained by chart abstraction. Regression analyses were constructed to determine key contributors to fatigue. RESULTS: The sample size included 84 pregnant women (mean age 31.3AE5.9 years, and mean gestational age 29.0AE7.6 weeks). Thirtysix percent of women reported that they were "often" fatigued, 46% screened positive for daytime sleepiness, and 42% had OSA. Demographics are shown in Table 1 . There was no association between fatigue and daytime sleepiness. In a logistic regression model, a complaint of fatigue was strongly associated with the presence of OSA (OR 5.1, 95%CI 1.4-19.3) after controlling for maternal age, gestational age, parity, BMI, race, and daytime sleepiness. CONCLUSION: Unrecognized OSA is a significant contributor to fatigue in pregnancy. Clinicians caring for pregnant women should consider OSA in women who are often fatigued. OBJECTIVE: Obesity has emerged as a leading cause of morbidity in reproductive aged women. It is associated with multiple maternal and fetal co-morbidities including pre-eclampsia, gestational diabetes and fetal growth restriction. It is also associated with obstructive sleep apnea (OSA), a treatable condition that is independently associated with gestational hypertension, pre-eclampsia, gestational diabetes, and fetal growth restriction. Despite the known association between obesity and OSA, pregnant women are rarely screened for OSA. Identification of high-risk women should be a priority in pregnancy as OSA can be treated. Thus, we investigated the relationship between the severity of obesity and the odds of objectively-assessed OSA. 
